Differential cytotoxicity of trace metals in cisplatin-sensitive and -resistant human ovarian cancer cells

被引:0
|
作者
Daniel L Nicholson
Susan M Purser
Robert H Maier
机构
[1] East Carolina University,Department of Surgery, Trace Element Center
来源
Biometals | 1998年 / 11卷
关键词
cisplatin; ctyotoxicity; metals; ovarian cancer;
D O I
暂无
中图分类号
学科分类号
摘要
Cellular resistance of cisplatin is related to variousfactors such as membrane transformations, changes incellular transport systems, andan increased efflux of cisplatin by the tumor cells. Deficiencies of one ormoretrace metals can affect normal physiological functions, leading to altered enzymaticactivities and areduction in immune responses. This in vitro investigation was undertaken tostudy and determine the differ-entialcytotoxicity of certain trace metals in humanovarian cancer cells that were sensitive and resistant tocisplatin. Standardcytotoxicity assays were performed using the neutral red assay. In general, thecisplatin-resistantcells exhibited an increased resistance to the externally supplied trace metals. For bothcell linesthe rank order of cytotoxicity from greatest to least with the non-essentialmetals was Cd >Bi , and forthe macrometals, Ca >K + >Mg . The transition metals and selenium exhibited a slight difference betweenthe two celllines with respect to the order of cytotoxicity. The cisplatin-sensitive cells had a rankorder ofV >Se >Cu >Zn >Fe , from greatest to least toxicity. The cisplatin-resistant cells had a rank orderof Cu >V >Se >Zn >Fe . Since trace metals have various functions in maintaining normal health,these results provide key baselinecytotoxicity data and show that, in general, cytotoxic resistance to thetrace metals testedfollowed a pattern similar to cellular cisplatin resistance.
引用
收藏
页码:259 / 263
页数:4
相关论文
共 50 条
  • [41] Quantitative mapping of platinum and essential trace metal in cisplatin resistant and sensitive human ovarian adenocarcinoma cells
    Ortega, R
    Moretto, P
    Fajac, A
    Benard, J
    Llabador, Y
    Simonoff, M
    [J]. CELLULAR AND MOLECULAR BIOLOGY, 1996, 42 (01) : 77 - 88
  • [42] Involvement of Akt/PKB signalling in survival of cisplatin-sensitive and -resistant human pulmonary mesothelioma cells
    Janson, V.
    Trinh, L. T.
    Behnam-Motlagh, P.
    Henriksson, R.
    Grankvist, K.
    [J]. EJC SUPPLEMENTS, 2005, 3 (02): : 333 - 334
  • [43] Difference in expression of Bcl-2 and Bcl-xl genes in cisplatin-sensitive and cisplatin-resistant human in ovarian cancer cell lines
    Yu Lili
    Wang Zehua
    [J]. Current Medical Science, 2004, 24 (2) : 151 - 153
  • [44] Cisplatin, hyperthermia and radiation treatment in human cisplatin-sensitive and resistant glioma cell lines
    Raaphorst, GP
    Yang, H
    Wilkins, DE
    Ng, CE
    [J]. INTERNATIONAL JOURNAL OF HYPERTHERMIA, 1996, 12 (06) : 801 - 812
  • [45] Difference in Expression of Bcl-2 and Bcl-xl Genes in Cisplatin-sensitive and Cisplatin-resistant Human in Ovarian Cancer Cell Lines
    于利利
    王泽华
    [J]. Current Medical Science, 2004, (02) : 151 - 153
  • [46] Obatoclax impairs lysosomal function to block autophagy in cisplatin-sensitive and -resistant esophageal cancer cells
    Yu, Le
    Wu, William K. K.
    Gu, Chunping
    Zhong, Desheng
    Zhao, Xuyan
    Kong, Yi
    Lin, Qinghuan
    Chan, Matthew T. V.
    Zhou, Zhitao
    Liu, Shuwen
    [J]. ONCOTARGET, 2016, 7 (12) : 14693 - 14707
  • [47] INHIBITION OF CISPLATIN ACCUMULATION BY 1,9-DIDEOXYFORSKOLIN IN CISPLATIN-SENSITIVE AND CISPLATIN-RESISTANT CELLS
    ANDREWS, PA
    JENNERWEIN, M
    MIDDLETON, JL
    [J]. FASEB JOURNAL, 1993, 7 (04): : A689 - A689
  • [48] Proteasome Inhibitor YSY01A Enhances Cisplatin Cytotoxicity in Cisplatin-Resistant Human Ovarian Cancer Cells
    Huang, Wei
    Zhou, Quan
    Yuan, Xia
    Ge, Ze-mei
    Ran, Fu-xiang
    Yang, Hua-yu
    Qiang, Guang-liang
    Li, Run-tao
    Cui, Jing-rong
    [J]. JOURNAL OF CANCER, 2016, 7 (09): : 1133 - 1141
  • [49] Cross-resistance and collateral sensitivity to natural product drugs in cisplatin-sensitive and resistant rat lymphoma and human ovarian carcinoma cells
    Parekh, H
    Simpkins, H
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1996, 37 (05) : 457 - 462
  • [50] Effect of combined treatment of Eribulin with Cisplatin in Cisplatin-sensitive (HEY) and Cisplatin-resistant (HEY-Cis) ovarian cancer cell lines
    Seeber, M.
    Koester, F.
    Polack, S.
    Rody, A.
    Braeutigam, K.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 180 - 180